Barclays raised its target for McKesson stock to USD 1,000.00
Published on 10/08/2026 at 15:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
McKesson (ISIN US58155Q1031) was trading at EUR 815.60 at Lang & Schwarz on October 8, 2026 at 2:59 p.m. CEST. According to MarketBeat on August 19, 2026, Barclays raised its McKesson target from USD 925.00 to USD 1,000.00.
Three milestones reshape the story
On July 21, 2026, McKesson's board raised the quarterly dividend by 15.00 percent to USD 0.94 per share, according to TickerScout.
On August 5, 2026, McKesson reported first-quarter fiscal 2027 revenue of USD 105.38 billion, up 7.70 percent year over year, while adjusted earnings per share reached USD 9.93 versus USD 9.56 consensus, according to MarketBeat.
On October 6, 2026, McKesson agreed with CD&R to acquire Option Care Health for USD 32.05 per share and an enterprise value of USD 5.8 billion, according to McKesson.
Quarterly scale meets guidance
McKesson reaffirmed fiscal 2027 adjusted earnings per share guidance of USD 44.20 to USD 45.00 on October 1, 2026, while extending its pharmaceutical distribution agreement with CVS Health through June 2032, according to McKesson.
The first-quarter revenue comparison shows the scale of the distributor's business, but the earnings comparison is more selective: adjusted earnings per share exceeded consensus by USD 0.37. That combination gives the Option Care investment a larger strategic backdrop than a standalone acquisition.
What comes next for McKesson?
McKesson will release second-quarter fiscal 2027 results on November 4, 2026, after the market close, with the earnings call scheduled for 4:30 p.m. ET. The Option Care transaction is expected to close in the first half of calendar year 2027, subject to approvals.
What does the deal add?
McKesson plans to invest USD 1.4 billion for a 49.00 percent minority interest, while CD&R will hold 51.00 percent, according to the October 6, 2026 release. The investment expands McKesson's exposure to home and alternate-site infusion care, while the ownership structure leaves CD&R with control and gives McKesson a framework to pursue the remaining stake later.
Stock quote and investor frame
At Lang & Schwarz, McKesson was trading at EUR 815.60 on October 8, 2026 at 2:59 p.m. CEST, plus 0.31 percent versus the prior close of EUR 813.10. The 52-week primary-exchange range was USD 723.68 to USD 999.00, while market capitalization stood at USD 106.6 billion as of October 7, 2026.
The further course of trading is shown by the continuously updated real-time quote of McKesson stock.
McKesson stock facts
- Company: McKesson Corporation
- ISIN: US58155Q1031
- WKN: 893953
- Ticker: MCK
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 8, 2026, 2:59 p.m. CEST: EUR 815.60
- Change versus prior close: plus 0.31 percent
- Prior close Lang & Schwarz October 7, 2026: EUR 813.10
- Market capitalization: USD 106.6 billion as of October 7, 2026
- 52-week range: USD 723.68-USD 999.00
- Sector / Industry: Healthcare / Medical distribution
- Index membership: S&P 500
- Next earnings date: November 4, 2026
Market context: Market report S&P 500.
